Back
PIMCO Dynamic Income Opportunities Fund Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison
Sell
46
PDO
PIMCO Dynamic Income Opportunities Fund
Last Price:
$13.83
Seasonality Move:
-6.56%
Buy
72
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$41.63
Seasonality Move:
-1.35%
Sell
46
PIMCO Dynamic Income Opportunities Fund (PDO)
is a Sell
Is PIMCO Dynamic Income Opportunities Fund a Buy, Sell or Hold?
-
The current PIMCO Dynamic Income Opportunities Fund [PDO] share price is $13.84. The Score for PDO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
PDO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $41.59. The Score for RIGL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PDO Stock Price Chart
What is PIMCO Dynamic Income Opportunities Fund's stock price today?
-
The PIMCO Dynamic Income Opportunities Fund share price today is $13.84Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PDO is experiencing slight selling pressure.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $41.59The current trend is moderately bearish and RIGL is experiencing selling pressure, which indicates risk of future bearish movement.
PDO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.6 | Buy |
| Relative Strength Index (14 RSI): | 47.03 | Sell |
| Chaikin Money Flow: | -212623 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.73 - 13.97) | Sell |
| Bollinger Bands (100): | (13.72 - 14.04) | Sell |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 48.4 | Sell |
| Chaikin Money Flow: | -1420728 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.45 - 47.99) | Sell |
| Bollinger Bands (100): | (29.17 - 43.09) | Buy |
PDO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.87 | Sell |
| 20-day SMA: | 13.9 | Sell |
| 50-day SMA: | 13.88 | Sell |
| 200-day SMA: | 13.66 | Buy |
| 8-day EMA: | 7.33 | Buy |
| 20-day EMA: | 3.59 | Buy |
| 50-day EMA: | 1.56 | Buy |
| 200-day EMA: | 0.41 | Buy |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.73 | Sell |
| 20-day SMA: | 45.09 | Sell |
| 50-day SMA: | 38.13 | Buy |
| 200-day SMA: | 27.66 | Buy |
| 8-day EMA: | 42.28 | Sell |
| 20-day EMA: | 42.74 | Sell |
| 50-day EMA: | 39.8 | Buy |
| 200-day EMA: | 30.28 | Buy |
PIMCO Dynamic Income Opportunities Fund Earnings Growth & PDO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
PIMCO Dynamic Income Opportunities Fund Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||